SCiAN Hosts Clinical Drug Development & Trial Designs Workshops in Philadelphia


TORONTO, ON – May 15th, 2019 – SCiAN Services is hosting 4 complimentary workshops at their Philadelphia location between May and June 2019.  The workshops are focused on clinical drug development and are aimed at providing valuable information to biotechnology companies who are in the early stages of their clinical program.

“The first clinical trial is of great significance for drug developers / biotechnology companies.  In our 30 years in this industry, SCiAN continues to plan, implement and execute these trials – the outflow of energy and excitement are immeasurable and the collaboration brings out the best of everyone involved, project management and technical/operations teams alike.  It is strikingly motivational for us to work on these studies.

With these workshops, we get to share our clinical expertise and more importantly, we give early drug developers a forum to ask questions and get answers, not only from us but from their fellow peers.  We are starting with key topics like phase I/II designs, how to select your lead indication and how to understand the nuances of sample size calculations, with the goal of adding more topics in the future” – Dr. Miklos Schulz, CEO, SCiAN Services.

To learn more about the workshops or to register, please visit:

SCiAN Clinical Drug Development Workshops

About SCiAN

SCiAN Services is a leading North American contract research organization (CRO) providing customized clinical trial services for clinical-stage start-ups and mid-size biotechnology companies.

For clinical-stage start-ups, we set-up, manage and execute all study activities from trial design, regulatory filing, trial management, DSMB, safety/DSUR updates, pharmacovigilance, data management, biostatistics and medical writing.

For mid-size bio-pharma companies, we offer large-scale biostatistics, statistical programming and data management services with high quality standards, timelines and deliverables maintained throughout the trial.

With 30+ years of experience in IND stage clinical trials and 690 studies completed, SCiAN’s therapeutic area expertise includes immune-oncology, oncology, CNS, infectious diseases, inflammatory / autoimmune diseases and diabetes.

For more information, please contact:

Jasna Szwagiel
Corporate Communication

Head Office
2150 Islington Avenue,
Suite 200
Toronto, ON, M9P 3V4

Ph: 416 231 8008
Fx: 416 416 231 1422

3675 Market Street,
6th Floor
Philadelphia, PA 19104

Ph: 267-244-8288

2950 Buskirk Ave,
Walnut Creek, CA 94597

Ph: 925-407-2069
Fx: 925-407-4769